Xiamen C&D has taken part in a $29.1m round for Jinda Nano Tech that will fuel the antibacterial product maker's research into nanotechnology.

China-based antibacterial technology developer Jinda Nano Tech secured approximately RMB200m ($29.1m) on Friday in a series B round featuring supply chain services provider Xiamen C&D, China Money Network reported. The round was led by venture capital firm Shunwei Capital, which disclosed the news on its WeChat account, and included participation from investment manager Blueprint Innovation.…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.